筋腫摘出術の世界市場レポート 2025年

筋腫摘出術の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は8.2％で、22億3,000万米ドルに成長すると予想されます。予測期間の成長は、妊孕性温存治療を求める女性の増加、婦人科専門医療へのアクセスの拡大、ヘルスケア技術革新への投資の増加、子宮疾患の有病率の増加、高度な外科的介入に対する医療費の増加などに起因すると考えられます。予測期間における世界の動向には、低侵襲手術やロボット支援手術技術、手術計画における人工知能の統合、遺伝子プロファイリングに基づく個別化治療計画の開発、非侵襲的診断ツールの進歩、妊孕性温存の選択肢を求める患者の増加、高度な手術技術への世界のアクセスの拡大、患者中心のケアと術後回復の改善への注力などが含まれます。

子宮疾患の有病率の増加は、筋腫摘出術市場の拡大を牽引すると予想されます。子宮疾患には、子宮筋腫、子宮内膜症、子宮がんなど、子宮に影響を及ぼすさまざまな疾患が含まれ、疼痛、異常出血、不妊などの症状を引き起こす可能性があります。子宮疾患の増加は、意識の高まり、出産の遅れ、ホルモンバランスの乱れ、ライフスタイルの変化などの要因と関連しています。筋腫摘出術は、子宮筋腫を子宮から摘出する手術で、子宮を温存しながら痛みや多量出血などの症状に対処します。例えば、Cancer Australiaが2024年1月に報告したところによると、子宮体がんによる死亡者数は2020年には561人で、2022年には667人に増加するとの予測が出ています。このように、子宮疾患の有病率の上昇が筋腫摘出術市場の成長に寄与しています。

低侵襲技術に対する需要の高まりが、今後数年間の筋腫摘出術市場の成長を促進すると予想されます。低侵襲手術は、小さな切開や自然な開口部を用いて内部構造、臓器、組織にアクセスし治療するもので、患者の体への外傷を軽減します。このような手技は、医療上、経済上、美容上の利点があり、患者とヘルスケア提供者の双方にアピールするため、さまざまな医療分野で需要が高まっています。低侵襲手術で一般的に使用される閉塞器具は、体内の血管、管、その他の経路を遮断または閉鎖するように設計された器具であり、動脈瘤、血流異常、先天性心疾患などの症状を治療するために、インターベンショナル心臓学や放射線学などの分野でしばしば採用されています。例えば、2023年1月、低侵襲医療製品を専門とする米国のIntuitive Surgical Inc.は、2022年に同社のダヴィンチ手術システムで約187万5,000件の外科手術が実施され、2021年の159万4,000件と比較して18％増加したと報告しました。その結果、低侵襲技術に対する需要の高まりが筋腫摘出術機器市場の成長を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の筋腫摘出術市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の筋腫摘出術市場：成長率分析
• 世界の筋腫摘出術市場の実績：規模と成長、2019～2024年
• 世界の筋腫摘出術市場の予測：規模と成長、2024～2029年、2034年
• 世界の筋腫摘出術総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の筋腫摘出術市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 腹式筋腫摘出術
• 子宮鏡下筋腫摘出術
• 腹腔鏡下筋腫摘出術
• 世界の筋腫摘出術市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 腹腔鏡電動モルセレータ
• ハーモニックメス
• 腹腔鏡シーラー
• その他
• 世界の筋腫摘出術市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院と診療所
• 外科センター
• 医療機器企業
• その他
• 世界の筋腫摘出術市場：腹式筋腫摘出術のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 開腹筋腫摘出術（開腹手術）
• 小開腹筋腫摘出術
• 世界の筋腫摘出術市場：子宮鏡下筋腫摘出術のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 切除鏡下筋腫摘出術
• 非切除鏡手術
• 世界の筋腫摘出術市場：腹腔鏡下筋腫摘出術のサブセグメンテーション、実績と予測、2019～2024年、2024～2029年、2034年
• 従来型腹腔鏡下筋腫摘出術
• ロボット支援腹腔鏡下筋腫摘出術

第7章 地域別・国別分析

• 世界の筋腫摘出術市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の筋腫摘出術市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 筋腫摘出術市場：競合情勢
• 筋腫摘出術市場：企業プロファイル
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Johnson Hopkins Medicines
• B. Braun Melsungen AG
• Olympus Corporation
• Intuitive Surgical Inc.
• Smith & Nephew plc
• Hologic Inc.
• Columbia University Irving Medical Center
• CooperSurgical Inc.
• Teleflex Incorporated
• Karl Storz SE & Co. KG
• CONMED Corporation
• Richard Wolf GmbH
• Park Hospital
• Phoenix Medical Devices
• ERBE Elektromedizin GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 筋腫摘出術市場2029：新たな機会を提供する国
• 筋腫摘出術市場2029：新たな機会を提供するセグメント
• 筋腫摘出術市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Myomectomy is a surgical procedure aimed at removing uterine fibroids, which are benign growths, while preserving the uterus. This procedure alleviates symptoms such as heavy bleeding, pain, and pressure related to fibroids and can improve fertility. It is often recommended for women who wish to retain their uterus.

The main types of myomectomy are abdominal myomectomy, hysteroscopic myomectomy, and laparoscopic myomectomy. Abdominal myomectomy involves removing fibroids through an incision in the abdomen, typically used for large or numerous fibroids as it provides direct access to the uterus. This procedure employs various products, such as laparoscopic power morcellators, harmonic scalpels, and laparoscopic sealers. End users include hospitals and clinics, surgical centers, and medical device companies.

The myomectomy market research report is one of a series of new reports from The Business Research Company that provides myomectomy market statistics, including myomectomy industry global market size, regional shares, competitors with a myomectomy market share, detailed myomectomy market segments, market trends and opportunities, and any further data you may need to thrive in the myomectomy industry. This myomectomy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The myomectomy market size has grown strongly in recent years. It will grow from $1.5 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to the growing prevalence of uterine fibroids, increasing advancements in surgical technology, increased awareness of treatment options, rising patient demand for effective solutions, and rising improvements in healthcare infrastructure.

The myomectomy market size is expected to see strong growth in the next few years. It will grow to $2.23 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to a rise in the number of women seeking fertility-preserving treatments, expanding access to specialized gynecological care, increasing investment in healthcare technology innovation, the growing prevalence of uterine disorders, rise in healthcare expenditure on advanced surgical interventions. Major trends in the forecast period include minimally invasive and robotic-assisted surgical techniques, integration of artificial intelligence in surgical planning, the development of personalized treatment plans based on genetic profiling, advancements in non-invasive diagnostic tools, a rise in patient demand for fertility-preserving options, expanding global access to advanced surgical technologies, focus on patient-centered care and postoperative recovery improvements.

The growing prevalence of uterine disorders is anticipated to drive the expansion of the myomectomy market. Uterine disorders encompass a variety of conditions affecting the uterus, such as fibroids, endometriosis, and uterine cancer, which can lead to symptoms such as pain, abnormal bleeding, and infertility. The increase in uterine disorders is linked to factors such as greater awareness, delayed childbearing, hormonal imbalances, and changes in lifestyle. Myomectomy is a surgical procedure used to remove fibroids from the uterus, addressing symptoms such as pain and heavy bleeding while preserving the uterus. For example, Cancer Australia reported in January 2024 that uterine cancer led to 561 deaths in 2020, with projections indicating an increase to 667 deaths by 2022. Thus, the rising prevalence of uterine disorders is fueling growth in the myomectomy market.

The increasing demand for minimally invasive techniques is expected to drive the growth of the myomectomy market in the coming years. Minimally invasive surgeries involve using small incisions or natural body openings to access and treat internal structures, organs, or tissues, reducing trauma to the patient's body. These techniques offer medical, financial, and aesthetic advantages that appeal to both patients and healthcare providers, leading to growing demand across various medical fields. Occlusion devices, commonly used in minimally invasive procedures, are tools designed to block or close off blood vessels, ducts, or other pathways in the body, often employed in fields like interventional cardiology and radiology to treat conditions such as aneurysms, abnormal blood flow, or congenital heart defects. For example, in January 2023, Intuitive Surgical Inc., a U.S.-based company specializing in minimally invasive care products, reported that approximately 1,875,000 surgical procedures were performed with their da Vinci surgical systems in 2022, marking an 18% increase compared to 1,594,000 procedures in 2021. As a result, the rising demand for minimally invasive techniques is fueling the growth of the myomectomy devices market.

Key players in the myomectomy market are concentrating on advancing gynecologic procedures, such as the development of tissue extraction systems to enhance surgical outcomes and offer minimally invasive options. The Tissue Extraction System is designed to aid in removing large tissue specimens during minimally invasive gynecologic surgeries, including myomectomy. For instance, in November 2022, Olympus Corporation, a Japan-based manufacturer, introduced the New Gynecologic Power Morcellator. This device, part of Olympus's tissue extraction system, is tailored for advanced gynecologic procedures involving large, calcified tissue specimens. When used with the PneumoLiner containment device, it offers a minimally invasive alternative to open hysterectomy or myomectomy.

Major companies operating in the myomectomy market are AbbVie Inc., Medtronic plc, Stryker Corporation, Mayo Clinic, Boston Scientific Corporation, Johnson Hopkins Medicines, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Smith & Nephew plc, Hologic Inc., Columbia University Irving Medical Center, CooperSurgical Inc., Teleflex Incorporated, Karl Storz SE & Co. KG, CONMED Corporation, Richard Wolf GmbH, Park Hospital , Phoenix Medical Devices, ERBE Elektromedizin GmbH, Advin Health Care, Sterling Surgicals, LiNA Medical ApS

North America was the largest region in the myomectomy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myomectomy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the myomectomy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The myomectomy market consists of revenues earned by entities by providing services such as preoperative evaluation, surgical techniques, anesthesia services, and fertility counseling and follow-up. The market value includes the value of related goods sold by the service provider or included within the service offering. The myomectomy market also includes sales of laparoscopic suturing devices, laparoscopic power morcellators, trocars, and laparoscopes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Myomectomy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on myomectomy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for myomectomy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The myomectomy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Abdominal Myomectomy; Hysteroscopic Myomectomy; Laparoscopic Myomectomy
• 2) By Product: Laparoscopic Power Morcellators; Harmonic Scalpel; Laparoscopic Sealer; Other Products
• 3) By End-User: Hospitals And Clinics; Surgical Centers; Medical Device Companies; Other End-Users
• Subsegments:
• 1) By Abdominal Myomectomy: Open Abdominal Myomectomy (Laparotomy); Mini-Laparotomy Myomectomy
• 2) By Hysteroscopic Myomectomy: Resectoscopic Myomectomy; Non-Resectoscopic Techniques
• 3) By Laparoscopic Myomectomy: Conventional Laparoscopic Myomectomy; Robotic-Assisted Laparoscopic Myomectomy
• Companies Mentioned: AbbVie Inc.; Medtronic plc; Stryker Corporation; Mayo Clinic; Boston Scientific Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Myomectomy Market Characteristics

3. Myomectomy Market Trends And Strategies

4. Myomectomy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Myomectomy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Myomectomy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Myomectomy Market Growth Rate Analysis
• 5.4. Global Myomectomy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Myomectomy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Myomectomy Total Addressable Market (TAM)

6. Myomectomy Market Segmentation

• 6.1. Global Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Abdominal Myomectomy
• Hysteroscopic Myomectomy
• Laparoscopic Myomectomy
• 6.2. Global Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laparoscopic Power Morcellators
• Harmonic Scalpel
• Laparoscopic Sealer
• Other Products
• 6.3. Global Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Surgical Centers
• Medical Device Companies
• Other End-Users
• 6.4. Global Myomectomy Market, Sub-Segmentation Of Abdominal Myomectomy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Open Abdominal Myomectomy (Laparotomy)
• Mini-Laparotomy Myomectomy
• 6.5. Global Myomectomy Market, Sub-Segmentation Of Hysteroscopic Myomectomy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Resectoscopic Myomectomy
• Non-Resectoscopic Techniques
• 6.6. Global Myomectomy Market, Sub-Segmentation Of Laparoscopic Myomectomy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Conventional Laparoscopic Myomectomy
• Robotic-Assisted Laparoscopic Myomectomy

7. Myomectomy Market Regional And Country Analysis

• 7.1. Global Myomectomy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Myomectomy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Myomectomy Market

• 8.1. Asia-Pacific Myomectomy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Myomectomy Market

• 9.1. China Myomectomy Market Overview
• 9.2. China Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Myomectomy Market

• 10.1. India Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Myomectomy Market

• 11.1. Japan Myomectomy Market Overview
• 11.2. Japan Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Myomectomy Market

• 12.1. Australia Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Myomectomy Market

• 13.1. Indonesia Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Myomectomy Market

• 14.1. South Korea Myomectomy Market Overview
• 14.2. South Korea Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Myomectomy Market

• 15.1. Western Europe Myomectomy Market Overview
• 15.2. Western Europe Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Myomectomy Market

• 16.1. UK Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Myomectomy Market

• 17.1. Germany Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Myomectomy Market

• 18.1. France Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Myomectomy Market

• 19.1. Italy Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Myomectomy Market

• 20.1. Spain Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Myomectomy Market

• 21.1. Eastern Europe Myomectomy Market Overview
• 21.2. Eastern Europe Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Myomectomy Market

• 22.1. Russia Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Myomectomy Market

• 23.1. North America Myomectomy Market Overview
• 23.2. North America Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Myomectomy Market

• 24.1. USA Myomectomy Market Overview
• 24.2. USA Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Myomectomy Market

• 25.1. Canada Myomectomy Market Overview
• 25.2. Canada Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Myomectomy Market

• 26.1. South America Myomectomy Market Overview
• 26.2. South America Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Myomectomy Market

• 27.1. Brazil Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Myomectomy Market

• 28.1. Middle East Myomectomy Market Overview
• 28.2. Middle East Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Myomectomy Market

• 29.1. Africa Myomectomy Market Overview
• 29.2. Africa Myomectomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Myomectomy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Myomectomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Myomectomy Market Competitive Landscape And Company Profiles

• 30.1. Myomectomy Market Competitive Landscape
• 30.2. Myomectomy Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Myomectomy Market Other Major And Innovative Companies

• 31.1. Johnson Hopkins Medicines
• 31.2. B. Braun Melsungen AG
• 31.3. Olympus Corporation
• 31.4. Intuitive Surgical Inc.
• 31.5. Smith & Nephew plc
• 31.6. Hologic Inc.
• 31.7. Columbia University Irving Medical Center
• 31.8. CooperSurgical Inc.
• 31.9. Teleflex Incorporated
• 31.10. Karl Storz SE & Co. KG
• 31.11. CONMED Corporation
• 31.12. Richard Wolf GmbH
• 31.13. Park Hospital
• 31.14. Phoenix Medical Devices
• 31.15. ERBE Elektromedizin GmbH

32. Global Myomectomy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Myomectomy Market

34. Recent Developments In The Myomectomy Market

35. Myomectomy Market High Potential Countries, Segments and Strategies

• 35.1 Myomectomy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Myomectomy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Myomectomy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33506_Myomectomy_GMR_2025